Poly Medicure Limited EBIT

The latest EBIT for POLYMED.NS is $4.1B as of June 2026. That compares with $4.1B in the prior-year period — down 1.5% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Poly Medicure Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, POLYMED.NS's EBIT moved from $4.1B to $4.1B — a 1.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Poly Medicure Limited's operating scale or balance-sheet position.

Against its sector companies, POLYMED.NS currently prints $4.1B for EBIT, while the sector average sits near $2.6T. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at Poly Medicure Limited's growth, margins, and balance sheet.

A EBIT figure of $4.1B for POLYMED.NS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting POLYMED.NS's EBIT ($4.1B), review year-over-year change from $4.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.